These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 21905034)
21. Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice. Flick-Smith HC; Eyles JE; Hebdon R; Waters EL; Beedham RJ; Stagg TJ; Miller J; Alpar HO; Baillie LW; Williamson ED Infect Immun; 2002 Apr; 70(4):2022-8. PubMed ID: 11895967 [TBL] [Abstract][Full Text] [Related]
22. Development of a novel multiepitope chimeric vaccine against anthrax. Aggarwal S; Somani VK; Gupta S; Garg R; Bhatnagar R Med Microbiol Immunol; 2019 Apr; 208(2):185-195. PubMed ID: 30671633 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model. Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303 [TBL] [Abstract][Full Text] [Related]
24. Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination. Bento D; Staats HF; Borges O Vaccine; 2015 Jul; 33(31):3609-13. PubMed ID: 26087299 [TBL] [Abstract][Full Text] [Related]
25. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Sloat BR; Cui Z Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937 [TBL] [Abstract][Full Text] [Related]
26. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. Sloat BR; Shaker DS; Le UM; Cui Z FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342 [TBL] [Abstract][Full Text] [Related]
27. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine. Zeng M; Xu Q; Pichichero ME Vaccine; 2007 May; 25(18):3588-94. PubMed ID: 17293013 [TBL] [Abstract][Full Text] [Related]
28. Induction of protective immunity against lethal anthrax challenge with a patch. Kenney RT; Yu J; Guebre-Xabier M; Frech SA; Lambert A; Heller BA; Ellingsworth LR; Eyles JE; Williamson ED; Glenn GM J Infect Dis; 2004 Aug; 190(4):774-82. PubMed ID: 15272406 [TBL] [Abstract][Full Text] [Related]
29. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax. Oscherwitz J; Feldman D; Yu F; Cease KB Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087 [TBL] [Abstract][Full Text] [Related]
30. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy. Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452 [TBL] [Abstract][Full Text] [Related]
31. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine. Little SF; Ivins BE; Webster WM; Norris SL; Andrews GP Vaccine; 2007 Apr; 25(15):2771-7. PubMed ID: 17240008 [TBL] [Abstract][Full Text] [Related]